# Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Study · id `cardio:ct-nct02742129` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02742129](<https://clinicaltrials.gov/study/NCT02742129>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02742129

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT02742129. Randomized; triple masking; primary purpose treatment. Start 2016-08-10 (actual); primary completion 2017-12-13 (actual). Results posted on 2019-03-13.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Started: 2016-08-10 (actual) (ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Primary completion: 2017-12-13 (actual) (ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Completion: 2017-12-27 (actual) (ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Results first posted: 2019-03-13 (ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02742129, source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02742129-2019-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
- Acronym: INDIE-HFpEF
- Condition: Heart Failure
- Intervention (Drug): Nebulized Sodium Nitrite
- Intervention (Drug): Placebo
- Lead sponsor: Adrian Hernandez
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Aires Pharmaceuticals, Inc.
- Collaborator class: INDUSTRY
- Collaborator: University of Vermont
- Collaborator class: OTHER
- Collaborator: Université de Montréal
- Collaborator class: OTHER
- Collaborator: Mayo Clinic
- Collaborator class: OTHER
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: University of Vermont (`cardio:org-university-of-vermont`)
- Registry lists this organization as a collaborator: Mayo Clinic (`cardio:org-mayo-clinic`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial (`cardio:pubmed-30398602`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3b9524e2af596f1df618c5a27e00f8767b7164f324b23b1d57e017dfef29fbad
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
